Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib dose escalation in ovarian cancer
NCT05961124Phase 2Recruiting
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Aug 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niraparib in ovarian cancer, sponsored by Sunnybrook Health Sciences Centre. Started Aug 2023; status: recruiting.
02
Drugs
niraparib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT05961124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05961124.